Heparin-Induced Thrombocytopenia

Heparin-Induced Thrombocytopenia (HIT) is a potentially life-threatening complication caused by a reaction to heparin, a commonly prescribed anticoagulant drug. It is characterized by a decrease in the number of platelets in the blood and can lead to an increased risk of clot formation and bleeding. Diagnosis of HIT is based on clinical evaluation and laboratory testing. Treatment involves discontinuation of heparin and the use of alternative anticoagulants. HIT can be prevented by using a variety of strategies, such as the use of alternative low-molecular-weight heparins and routine monitoring of platelet counts. The timely diagnosis and management of HIT is essential for optimal patient outcomes.